Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

565
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
565
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

485
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
485
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

440
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
440

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes.

Eye (London, England)·2026
Same author

Comorbidity of uveitis and multiple sclerosis.

Multiple sclerosis and related disorders·2026
Same author

Reduced rates of intraocular surgeries in anterior uveitis.

Acta ophthalmologica·2026
Same author

Potent Neuronal Nicotinamide Adenine Dinucleotide-Boosting Tetrahydroquinoxalines: Structure-Activity Relationships and Early Drug Metabolism and Pharmacokinetics Evaluation.

ACS medicinal chemistry letters·2026
Same author

Deep learning in population-based screening for glaucoma.

The British journal of ophthalmology·2026
Same author

Referral for glaucoma surgery and types of surgery in different European regions in 2025, the EURACCUR study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026

Related Experiment Video

Updated: Jun 29, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.4K

Missed Opportunities in Screening for Glaucoma.

Anja Tuulonen1, Sanna Leinonen1,2, Gauti Jóhannesson3,4,5

  • 1Tays Eye Centre, Tampere University Hospital, Tampere, Finland.

Journal of Glaucoma
|April 4, 2024
PubMed
Summary

Screening systems face challenges like variable care and rising costs, even when evidence doesn

More Related Videos

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K

Related Experiment Videos

Last Updated: Jun 29, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.4K
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K

Area of Science:

  • Ophthalmology
  • Public Health
  • Health Systems Research

Background:

  • Screening programs face universal challenges including care variability, over/under-treatment, and escalating costs.
  • These issues are present in both developed and developing nations, with the Western world finding 'more' is not a sustainable solution.
  • Screening effectiveness must balance benefits against harms (over-diagnosis, false positives/negatives) and be cost-effective.

Purpose of the Study:

  • To provide a comprehensive overview of current knowledge, understanding, and challenges in general screening.
  • To specifically address the complexities and limitations of glaucoma screening.

Main Methods:

  • Literature review to synthesize existing data on screening practices and outcomes.
  • Analysis of systemic challenges, including care variability, cost, and ethical considerations.
  • Consideration of factors influencing screening trial design and interpretation, such as commercial interests and politics.

Main Results:

  • All screening systems exhibit significant variability in care practices, despite guidelines.
  • Screening often leads to a dichotomy of under-care and over-care, coupled with unsustainable cost increases.
  • Even without supporting evidence, screening may be pursued for perceived action, influenced by commercial and political factors.

Conclusions:

  • A public health perspective is crucial for sustainable eye care, balancing the needs of high-risk individuals with population-wide over-diagnosis.
  • Addressing screening biases and care variability makes high-quality randomized controlled trials for glaucoma screening exceptionally challenging.
  • Future strategies must focus on efficient resource allocation to identify and treat underserved high-risk populations without overburdening the healthcare system.